Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Jim Crowley

Urology Provo, UT Medical Doctor

NPI 1083697957 CMS profile 48973

1055 N 500 W, Suite 211, Provo, UT 84604

Open in the dashboard

General payments

$7,855

66 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Jim Crowley of Provo, UT is reported in the CMS Open Payments database as having received $7,855 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $5,829 10
2022 General $706 8
2021 General $263 8
2020 General $345 14
2019 General $713 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jim Crowley
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Jim Crowley were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Jim Crowley Urology median Middle half National median
2019 $713 $480 $147–$1,201 $163
2020 $345 $246 $87–$645 $114
2021 $263 $358 $111–$1,000 $132
2022 $706 $476 $143–$1,263 $149
2023 $5,829 $560 $168–$1,461 $160
2024 $0 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Intuitive Surgical, Inc. $6,361 13 payments
  2. Boston Scientific Corporation $1,057 27 payments
  3. 180 Medical, Inc. $94 5 payments
  4. Astellas Pharma US Inc $92 5 payments
  5. Pfizer Inc. $65 4 payments
  6. Janssen Biotech, Inc. $49 3 payments
  7. Dendreon Pharmaceuticals LLC $42 2 payments
  8. AbbVie, Inc. $20 1 payment
  9. Coloplast Corp $18 1 payment
  10. Urogen Pharma, Inc. $15 1 payment
  11. Other $42 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Education $4,504 3 payments
  2. Travel and Lodging $1,806 8 payments
  3. Food and Beverage $1,545 55 payments
Products named General payments · program years 2019–2023
  1. DAVINCI XI $4,500 2 payments
  2. Da Vinci Surgical System $1,750 9 payments
  3. LITHOVUE Scope $424 12 payments
  4. LITHOVUE EMPOWER $118 1 payment
  5. XTANDI $115 7 payments
  6. DA VINCI SP $111 2 payments
  7. LITHOVUE Scope $110 2 payments
  8. LithoVue LithoVue_URO $79 2 payments
  9. TOVIAZ $65 4 payments
  10. ERLEADA $62 4 payments
  11. Other $494 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record